In vitro antimalarial activity of different extracts of Eremostachys macrophylla Montbr. & Auch.

• Main Authors: Solmaz Asnaashari, Fariba Heshmati Afshar, Atefeh Ebrahimi, Sedigheh Bamdad Moghaddam, Abbas Delazar
• Format: Article
• Language: English
• Published: Tabriz University of Medical Sciences 2015-08-01
• Series: BioImpacts
• Subjects: Eremostachys macrophylla; Antimalaria; Cell free assay; GC-MS
• Online Access: http://journals.tbzmed.ac.ir/BI/PDF/BI-5-135.pdf

Introduction: The risk of drug resistance and the use of medicinal plants in malaria prevention and treatment have led to the search for new antimalarial compounds with natural origin. Methods: In the current study, six extracts with different polarity from aerial parts and rhizomes of Eremostachys macrophylla Montbr. & Auch., were screened for their antimalarial properties by cell-free beta-hematin formation assay. Results: Dichloromethane (DCM) extracts of both parts of plant showed significant antimalarial activities with IC50 values of 0.797 ± 0.016 mg/mL in aerial parts and 0.324 ± 0.039 mg/mL in rhizomes compared to positive control (Chloroqui​ne, IC50 = 0.014 ± 0.003 mg/mL, IC90 = 0.163 ± 0.004 mg/mL). Bioactivity-guided fractionation of the most potent part (DCM extract of rhizomes) by vacuum liquid chromatography (VLC) afforded seven fractions. Sixty percent ethyl acetate/n-hexane fraction showed considerable antimalarial activity with IC50 value of 0.047 ± 0.0003 mg/mL. Conclusion: From 6 extracts with different polarity of E. macrophylla's aerial parts and rhizomes, the DCM extract of both parts were the most active extract in this assay. The preliminary phytochemical study on the VLC fractions of the most potent part persuades us to focus on purifying the active components of these extracts and to conduct further investigation towards in vivo evaluation.